News

Categories

May 19, 2025

Zymeworks Presents Preclinical Data on ZW1528 at the American Thoracic Society International Conference

April 25, 2025

Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting

March 31, 2025

Zymeworks to Present Preclinical Data on ZW1528 at the American Thoracic Society Annual Meeting

March 25, 2025

Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting

December 12, 2024

Zymeworks Hosts R&D Day Highlighting Continued Clinical Progress in Oncology Programs and Expansion into Autoimmune and Inflammatory Diseases

November 21, 2024

Zymeworks Announces Participation in Upcoming Investor Conferences

November 7, 2024

Zymeworks Presents Preclinical Data on ZW171 at the Society for Immunotherapy of Cancer (SITC) Conference

November 5, 2024

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors

October 25, 2024

Zymeworks Presents New Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference

October 21, 2024

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers

October 9, 2024

Zymeworks Presents New Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference

October 8, 2024

Dr. Raffaele Colombo Honored as a PharmaVoice 100 Winner